Important role for Rac1 in regulating reactive oxygen species generation and pulmonary arterial smooth muscle cell growth

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 287, Issue 6 31-6, 2004, Pages

  Patil, Sandip ^a   Bunderson, Melisa ^b   Wilham, Jason ^b   Black, Stephen M ^b,c  

^a NORTHWESTERN UNIVERSITY   (United States)

^b UNIVERSITY OF MONTANA   (United States)

^c St Patrick Hospital and Health Sciences Center   (United States)

Author keywords

Vascular reduced nicotinamide adenine dinucleotide phosphate oxidase

Indexed keywords

COPPER ZINC SUPEROXIDE DISMUTASE; DIETHYLDITHIOCARBAMIC ACID; ENZYME INHIBITOR; GERANYLTRANSFERASE; GGTI 287; RAC1 PROTEIN; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL CYCLE; CELL GROWTH; CONTROLLED STUDY; ENZYME ACTIVATION; GENE EXPRESSION; GENE TRANSFER; GROWTH INHIBITION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PULMONARY ARTERY; SHEEP; SMOOTH MUSCLE FIBER;

ANIMALS; CELL DIVISION; CELLS, CULTURED; LEUCINE; MUSCLE, SMOOTH, VASCULAR; PULMONARY ARTERY; RAC1 GTP-BINDING PROTEIN; REACTIVE OXYGEN SPECIES; SHEEP;

EID: 8644226953     PISSN: 10400605     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajplung.00383.2003     Document Type: Article

References (42)

1. Abo A, Pick E, Hall A, Totty N, Teahan CG, and Segal AW. Activation of the NADPH oxidase involves the small GTP-binding protein p21rac1. Nature 353: 668-670, 1991.
2. Adnane J, Bizouarn FA, Qian Y, Hamilton AD, and Sebti SM. p21(WAF1/CIP1) is upregulated by the geranylgeranyltransferase I inhibitor GGTI-298 through a transforming growth factor beta- and Sp1-responsive element: involvement of the small GTPase rhoA. Mol Cell Biol 18: 6962-6970, 1998.
3. Berry C, Hamilton CA, Brosnan MJ, Magill FG, Berg GA, McMurray JJ, and Dominiczak AF. Investigation into the sources of superoxide in human blood vessels: angiotensin II increases superoxide production in human internal mammary arteries. Circulation 101: 2206-2212, 2000.
4. Bokoch GM and Diebold BA. Current molecular models for NADPH oxidase regulation by Rac GTPase. Blood 100: 2692-2696, 2002.
5. Brennan L, Steinhorn RH, Wedgwood S, Mata-Greenwood E, Roark EA, Russell JA, and Black SM. Increased superoxide generation is associated with pulmonary hypertension in fetal lambs: a role for NADPH oxidase. Circ Res 92: 683-691, 2003.
6. Casey PJ. Biochemistry of protein prenylation. J Lipid Res 33: 1731-1740, 1992.
7. Crouch S, Kozlowski R, Slater K, and Fletcher J. The use of ATP bioluminescence as a measure of cell proliferation and cytotoxicity. J Immunol Methods 160: 81-88, 1993.
8. Diatchuk V, Lotan O, Koshkin V, Wikstroem P, and Pick E. Inhibition of NADPH oxidase activation by 4-(2-aminoethyl)-benzenesulfonyl fluoride and related compounds. J Biol Chem 272: 13292-13301, 1997.
9. Dorseuil O, Reibel L, Bokoch GM, Camonis J, and Gacon G. The Rac target NADPH oxidase p67 interacts preferentially with Rac2 rather than Rac1. J Biol Chem 271: 83-88, 1996.
10. Griendling KK, Minieri CA, Ollerenshaw JD, and Alexander RW. Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res 74: 1141-1148, 1994.
11. Griendling KK, Sorescu D, and Ushio-Fukai M. NAD(P)H oxidase: role in cardiovascular biology and disease. Circ Res 86: 494-501, 2000.
12. Grunfeld S, Hamilton CA, Mesaros S, McClain SW, Dominiczak AF, Bohr DF, and Malinski T. Role of superoxide in the depressed nitric oxide production by the endothelium of genetically hypertensive rats. Hypertension 26: 854-857, 1995.
13. Irani K, Xia Y, Zweier JL, Sollott SJ, Der CJ, Fearon ER, Sundaresan M, Finkel T, and Goldschmidt-Clermont PJ. Mitogenic signaling mediated by oxidants in Ras-transformed fibroblasts. Science 275: 1649-1652, 1997.
14. Knaus U, Heyworth PG, Evans T, Curnutte JT, and Bokoch GM. Regulation of phagocyte oxygen radical production by the GTP-binding protein Rac 2. Science 254: 1512-1515, 1991.
15. Knaus UG, Heyworth PG, Kinsella BT, Curnutte JT, and Bokoch GM. Purification and characterization of Rac 2. A cytosolic GTP-binding protein that regulates human neutrophil NADPH oxidase. J Biol Chem 267: 23575-23582, 1992.
16. Krieger-Brauer HI, Medda P, and Kather H. Basic fibroblast growth factor utilizes both types of component subunits of Gs for dual signaling in human adipocytes. Stimulation of adenylyl cyclase via Galph(s) and inhibition of NADPH oxidase by Gbeta gamma(s). J Biol Chem 275: 35920-35925, 2000.
17. Larochelle DA, Vithalani KK, and De Lozanne A. A novel member of the rho family of small GTP-binding proteins is specifically required for cytokinesis. J Cell Biol 133: 1321-1329, 1996.
18. 2 signals 5-HT-induced ERK MAP kinase activation and mitogenesis of smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 281: L646-L652, 2001.
19. Lee SL, Wang WW, and Fanburg BL. Superoxide as an intermediate signal for serotonin-induced mitogenesis. Free Radic Biol Med 24: 855-858, 1998.
20. Leusen J, Verhoeven AJ, and Roos D. Interactions between the components of the human NADPH oxidase: intrigues in the phox family. J Lab Clin Med 128: 461-476, 1996.
21. Marumo T, Schini-Kerth VB, Fisslthaler B, and Busse R. Platelet-derived growth factor-stimulated superoxide anion production modulates activation of transcription factor NF-kappaB and expression of monocyte chemoattractant protein 1 in human aortic smooth muscle cells. Circulation 96: 2361-2367, 1997.
22. Mazet JL, Padieu M, Osman H, Maume G, Mailliet P, Dereu N, Hamilton AD, Lavelle F, Sebti SM, and Maume BF. Combination of the novel farnesyltransferase inhibitor RPR130401 and the geranylgeranyltransferase-1 inhibitor GGTI-298 disrupts MAP kinase activation and G(1)-S transition in Ki-Ras-overexpressing transformed adrenocortical cells. FEBS Lett 460: 235-240, 1999.
23. Mohazzab KM and Wolin MS. Sites of superoxide anion production detected by lucigenin in calf pulmonary artery smooth muscle. Am J Physiol Lung Cell Mol Physiol 267: L815-L822, 1994.
24. Moore KA, Sethi R, Doanes AM, Johnson TM, Pracyk JB, Kirby M, Irani K, Goldschmidt-Clermont PJ, and Finkel T. Rac1 is required for cell proliferation and G2/M progression. Biochem J 326: 17-20, 1997.
25. Ohara Y, Peterson T, and Harrison D. Hypercholesterolemia increases endothelial superoxide anion production. J Clin Invest 91: 2546-2551, 1993.
26. Pagano PJ, Ito Y, Tornheim K, Gallop PM, Tauber AI, and Cohen RA. An NADPH oxidase superoxide-generating system in the rabbit aorta. Am J Physiol Heart Circ Physiol 268: H2274-H2280, 1995.
27. Patterson C, Ruef J, Madamanchi NR, Barry-Lane P, Hu Z, Horaist C, Ballinger CA, Brasier AR, Bode C, and Runge MS. Stimulation of a vascular smooth muscle cell NAD(P)H oxidase by thrombin. Evidence that p47(phox) may participate in forming this oxidase in vitro and in vivo. J Biol Chem 274: 19814-19822, 1999.
28. Rajagopalan S, Kurz S, Münzel T, Tarpey M, Freeman BA, Griendling KK, and Harrison DG. Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone. J Clin Invest 97: 1916-1923, 1996.
29. Rinckel LA, Faris SL, Hitt ND, and Kleinberg ME. Rac1 disrupts p67phox/p40phox binding: a novel role for Rac in NADPH oxidase activation. Biochem Biophys Res Commun 263: 118-122, 1999.
30. Ross R. A pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362: 801-809, 1993.
31. Stark WW Jr, Blaskovich MA, Johnson BA, Qian Y, Vasudevan A, Pitt B, Hamilton AD, Sebti SM, and Davies P. Inhibiting geranylgeranylation blocks growth and promotes apoptosis in pulmonary vascular smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 275: L55-L63, 1998.
32. Sulciner DJ, Irani K, Yu ZX, Ferrans VJ, Goldschmidt-Clermont P, and Finkel T. Rac1 regulates a cytokine-stimulated, redox-dependent pathway necessary for NF-kappaB activation. Mol Cell Biol 12: 7115-7121, 1996.
33. Sun J, Qian Y, Chen Z, Marfurt J, Hamilton AD, and Sebti SM. The geranylgeranyltransferase I inhibitor GGTI-298 induces hypophosphorylation of retinoblastoma and partner switching of cyclin-dependent kinase inhibitors. A potential mechanism for GGTI-298 antitumor activity. J Biol Chem 274: 6930-6934, 1999.
34. 2 for platelet-derived growth factor signal transduction. Science 270: 296-299, 1995.
35. Sundaresan M, Yu ZX, Ferrans VJ, Sulciner DJ, Gutkind JS, Irani K, Goldschmidt-Clermont PJ, and Finkel T. Regulation of reactive-oxygen-species generation in fibroblasts by Rac1. Biochem J 318: 379-382, 1996.
36. Vignais PV. The superoxide-generating NADPH oxidase: structural aspects and activation mechanism. Cell Mol Life Sci 59: 1428-1459, 2002.
37. Wassmann S, Laufs U, Muller K, Konkol C, Ahlbory K, Baumer AT, Linz W, Bohm M, and Nickenig G. Cellular antioxidant effects of atorvastatin in vitro and in vivo. Arterioscler Thromb Vasc Biol 22: 300-305, 2002.
38. Wassmann S, Laufs U, Stamenkovic D, Linz W, Stasch JP, Ahlbory K, Rosen R, Bohm M, and Nickenig G. Raloxifene improves endothelial dysfunction in hypertension by reduced oxidative stress and enhanced nitric oxide production. Circulation 105: 2083-2091, 2002.
39. Wedgwood S and Black SM. Combined superoxide dismutase/catalase mimetics alter fetal pulmonary arterial smooth muscle cell growth. Anti-oxid Redox Signal 6: 191-197, 2004.
40. Wedgwood S and Black SM. Induction of apoptosis in fetal pulmonary arterial smooth muscle cells by a combined superoxide dismutase/catalase mimetic. Am J Physiol Lung Cell Mol Physiol 285: L305-L312, 2003.
41. Wedgwood S, Dettman R, and Black S. ET-1 stimulates pulmonary arterial smooth muscle cell proliferation via induction of reactive oxygen species. Am J Physiol Lung Cell Mol Physiol 281: L1058-L1067, 2001.
42. Wedgwood S, McMullan DM, Bekker JM, Fineman JR, and Black SM. Role for endothelin-1-induced superoxide and peroxynitrite production in rebound pulmonary hypertension associated with inhaled nitric oxide therapy. Circ Res 89: 357-364, 2001.